Does DAROLUTAMIDE Cause Epistaxis? 17 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Epistaxis have been filed in association with DAROLUTAMIDE (NUBEQA). This represents 0.5% of all adverse event reports for DAROLUTAMIDE.
17
Reports of Epistaxis with DAROLUTAMIDE
0.5%
of all DAROLUTAMIDE reports
1
Deaths
7
Hospitalizations
How Dangerous Is Epistaxis From DAROLUTAMIDE?
Of the 17 reports, 1 (5.9%) resulted in death, 7 (41.2%) required hospitalization.
Is Epistaxis Listed in the Official Label?
Yes, Epistaxis is listed as a known adverse reaction in the official FDA drug label for DAROLUTAMIDE.
What Other Side Effects Does DAROLUTAMIDE Cause?
Fatigue (384)
Death (361)
Hot flush (203)
Asthenia (173)
Prostatic specific antigen increased (156)
Off label use (133)
Neuropathy peripheral (127)
Diarrhoea (122)
Dizziness (122)
Rash (116)
What Other Drugs Cause Epistaxis?
RIVAROXABAN (5,629)
ASPIRIN (3,214)
APIXABAN (2,831)
FLUTICASONE (1,745)
TREPROSTINIL (1,726)
CLOPIDOGREL BISULFATE (1,560)
BEVACIZUMAB (1,542)
WARFARIN (1,498)
PALBOCICLIB (1,280)
ADALIMUMAB (1,243)
Which DAROLUTAMIDE Alternatives Have Lower Epistaxis Risk?
DAROLUTAMIDE vs DARUNAVIR
DAROLUTAMIDE vs DARUNAVIR ETHANOLATE
DAROLUTAMIDE vs DARUNAVIR\RITONAVIR
DAROLUTAMIDE vs DASABUVIR
DAROLUTAMIDE vs DASABUVIR\OMBITASVIR HEMINONAHYDRATE\PARITAPREVIR\RITONAVIR